Literature DB >> 32467591

Endovascular stroke treatment during the COVID-19 pandemic.

Johanna M Ospel1,2, Mayank Goyal3,4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32467591      PMCID: PMC7254971          DOI: 10.1038/s41582-020-0371-1

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
Refers to Smith, M. S. et al. Endovascular therapy for patients with acute ischemic stroke during the COVID-19 pandemic: a proposed algorithm. Stroke 10.1161/STROKEAHA.120.029863 (2020). | Nguyen, T. N. et al. Mechanical thrombectomy in the era of the COVID-19 pandemic: emergency preparedness for neuroscience teams: a guidance statement from the Society of Vascular and Interventional Neurology. Stroke 10.1161/STROKEAHA.120.030100 (2020). The COVID-19 pandemic presents substantial challenges for acute stroke treatment. Not only do patients with COVID-19 seem to be more vulnerable to cerebral ischaemia[1], but the need to screen patients with acute stroke for COVID-19 symptoms and impose additional protective measures to promote infectious control in the ambulance and neuroangiography suite and on hospital wards carries the risk of substantial treatment delays. Endovascular treatment (EVT) for stroke is a powerful approach[2], but its benefits diminish as time to treatment increases[3]. Staff shortages due to illness, quarantining and emergency redeployment further complicate the issue. Two recent articles from the University of Cincinnati (Smith et al.[4]) and the Society of Vascular and Interventional Neurology (Nguyen et al.[5]) provide concrete guidance on how to minimize delays to EVT while keeping the risk of infectious exposure for patients and staff at a minimum. Specific workflow steps might vary depending on the local set-up, but the articles emphasize six key principles to ensure safe and timely EVT in the COVID-19 era: transfer of key knowledge, clinical practice, standardization and simplification, individualization, flexibility and teamwork (Fig. 1).
Fig. 1

COVID-19-related challenges in EVT workflows.

The figure illustrates how the COVID-19 pandemic is likely to influence endovascular treatment (EVT) for acute ischaemic stroke in the pre-hospital and in-hospital phases. CSC, comprehensive stroke centre; LVO, large vessel occlusion; mCTA, multiphase CT angiography; NCCT, non-contrast CT; PPE, personal protective equipment; PSC, primary stroke centre. aSee first figure in ref.[4]. bSee second figure in ref.[4]. cAs described and used in previous trials[7–9]. dFor a detailed description of EVT workflows in the neuroangiography suite, see ref.[4]. eSee ‘Postacute care’ section in ref.[5]. fPost-EVT neurological assessment schedule as proposed in ref.[4].

COVID-19-related challenges in EVT workflows.

The figure illustrates how the COVID-19 pandemic is likely to influence endovascular treatment (EVT) for acute ischaemic stroke in the pre-hospital and in-hospital phases. CSC, comprehensive stroke centre; LVO, large vessel occlusion; mCTA, multiphase CT angiography; NCCT, non-contrast CT; PPE, personal protective equipment; PSC, primary stroke centre. aSee first figure in ref.[4]. bSee second figure in ref.[4]. cAs described and used in previous trials[7-9]. dFor a detailed description of EVT workflows in the neuroangiography suite, see ref.[4]. eSee ‘Postacute care’ section in ref.[5]. fPost-EVT neurological assessment schedule as proposed in ref.[4]. The COVID-19 pandemic requires fast and flexible reallocation of hospital staff and resources. To seamlessly integrate new staff into existing stroke teams, new team members must be taught the key knowledge that is necessary for acute stroke treatment and infectious disease control, for example, how to screen patients for COVID-19 symptoms, as summarized in a figure in the Smith et al. paper[4], and how to administer intravenous thrombolysis. The COVID-19 pandemic requires fast and flexible reallocation of hospital staff and resources Smith et al.[4] describe a range of workflow changes in stroke treatment — in particular, mechanical thrombectomy — that are required during the COVID-19 pandemic, including additional personal protective equipment (PPE) and respiratory screening measures. Such changes often lead to uncertainty among the members of the stroke team. Rehearsing COVID-19 stroke workflows, such as through simulation training, is crucial to effectively identify safety threats and familiarize the stroke team with COVID-19-related workflow changes, such as donning and doffing of PPE, thereby minimizing treatment delays[6]. Nguyen and colleagues suggest that an observer should watch team members don and doff their gown and PPE to identify potential breaches in viral protection[5]. To minimize confusion and treatment delays, imaging protocols and workflow steps should be as standardized and simple as possible, as outlined in an algorithm in the paper by Smith et al.[4]. For example, standardized criteria for intubation prior to EVT help to avoid discussions and minimize treatment delays[4]. Nguyen et al. suggest designating a COVID-19 neuroangiography suite in which all stroke patients with suspected and/or confirmed COVID-19 are treated[5]. The thrombectomy procedure itself should also be standardized, with a pre-prepared thrombectomy kit readily available, to reduce the cognitive load for operators, technicians and nurses. Hospital set-ups, health-care infrastructures and resources are unique to each centre; thus, workflows and responsibilities of health-care workers will vary. Consequently, protocols need to be individualized according to the local circumstances. For example, large hospitals could have a dedicated CT scanner for patients with suspected or confirmed COVID-19, as described by Smith et al.[4]. In smaller hospitals, such spatial separation might not be possible, so additional precautions will be necessary to protect other patients. The COVID-19 pandemic is a rapidly evolving situation with infection rates, staff resources and availability of hospital beds and PPE constantly changing. Stroke workflows and post-stroke care strategies need to be flexible and adapt to new developments and available resources, as both articles point out. If the COVID-19 caseload on the stroke unit of a particular hospital exceeds the staff capacity, for instance, it will become necessary to alter pre-hospital transport paradigms and reroute acute stroke patients with suspected or confirmed COVID-19 infection to another, more distant hospital. The physical and mental strain on health-care workers during the COVID-19 pandemic is substantial, and teamwork is crucial to alleviate stress and avoid burnout. Nguyen and colleagues emphasize that frontline health-care workers are particularly vulnerable to depression and anxiety[5]. Open communication, a non-judgmental atmosphere and a willingness to listen to problems and concerns of colleagues are important to build trust among team members and facilitate smooth integration of new staff into existing teams. The physical and mental strain on health-care workers during the COVID-19 pandemic is substantial In conclusion, acute ischaemic stroke is a highly time-dependent condition, and the rapid initiation of treatment remains vital in the COVID-19 era. In their articles, Nguyen et al. and Smith et al. highlight the challenges that stroke teams encounter when trying to balance the risk of infectious exposure for health-care workers and patients against the available resources and the need for timely EVT[4,5]. Herein, we have outlined six key principles that can help to ensure timely and safe EVT while minimizing infectious exposure of staff and patients. However, as both articles acknowledge, the specific steps of the COVID-19 EVT workflow will vary according to local infrastructures and resources and will need to change over time as the COVID-19 situation evolves.
  3 in total

1.  Considerations in Adult Congenital Heart Disease and Stroke: A Case Report.

Authors:  Nelson Lu; Jonathan M C Smith; Jason G Andrade; Alana M Flexman; Thalia S Field
Journal:  Stroke       Date:  2020-06-24       Impact factor: 7.914

2.  Mechanical Thrombectomy in the Era of the COVID-19 Pandemic: Emergency Preparedness for Neuroscience Teams: A Guidance Statement From the Society of Vascular and Interventional Neurology.

Authors:  Thanh N Nguyen; Mohamad Abdalkader; Tudor G Jovin; Raul G Nogueira; Ashutosh P Jadhav; Diogo C Haussen; Ameer E Hassan; Roberta Novakovic; Sunil A Sheth; Santiago Ortega-Gutierrez; Peter D Panagos; Steve M Cordina; Italo Linfante; Ossama Yassin Mansour; Amer M Malik; Sandra Narayanan; Hesham E Masoud; Sherry Hsiang-Yi Chou; Rakesh Khatri; Vallabh Janardhan; Dileep R Yavagal; Osama O Zaidat; David M Greer; David S Liebeskind
Journal:  Stroke       Date:  2020-04-29       Impact factor: 7.914

3.  Large-Vessel Stroke as a Presenting Feature of Covid-19 in the Young.

Authors:  Thomas J Oxley; J Mocco; Shahram Majidi; Christopher P Kellner; Hazem Shoirah; I Paul Singh; Reade A De Leacy; Tomoyoshi Shigematsu; Travis R Ladner; Kurt A Yaeger; Maryna Skliut; Jesse Weinberger; Neha S Dangayach; Joshua B Bederson; Stanley Tuhrim; Johanna T Fifi
Journal:  N Engl J Med       Date:  2020-04-28       Impact factor: 91.245

  3 in total
  4 in total

1.  Modification of Acute Stroke Pathway in Korea After the Coronavirus Disease 2019 Outbreak.

Authors:  Tae Jung Kim; Beom Joon Kim; Dong-Seok Gwak; Ji Sung Lee; Jun Yup Kim; Keon-Joo Lee; Jung-A Kwon; Dong-Hyun Shim; Yong-Won Kim; Min Kyoung Kang; Eung-Jun Lee; Ki-Woong Nam; Jeonghoon Bae; Kipyoung Jeon; Han-Yeong Jeong; Keun-Hwa Jung; Yang-Ha Hwang; Hee-Joon Bae; Byung-Woo Yoon; Sang-Bae Ko
Journal:  Front Neurol       Date:  2020-11-19       Impact factor: 4.003

Review 2.  The Unfolding Palette of COVID-19Multisystemic Syndrome and its Neurological Manifestations.

Authors:  Francisco J Barrantes
Journal:  Brain Behav Immun Health       Date:  2021-04-03

3.  Changes in ischemic stroke presentations, management and outcomes during the first year of the COVID-19 pandemic in Alberta: a population study.

Authors:  Aravind Ganesh; Jillian M Stang; Finlay A McAlister; Oleksandr Shlakhter; Jessalyn K Holodinsky; Balraj Mann; Michael D Hill; Eric E Smith
Journal:  CMAJ       Date:  2022-03-28       Impact factor: 8.262

4.  Ignorance is not bliss: managing uncertainty in acute stroke treatment in the COVID-19 era.

Authors:  Aravind Ganesh; Johanna M Ospel; Julie Kromm; Mayank Goyal
Journal:  Neuroradiology       Date:  2020-10-31       Impact factor: 2.804

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.